Diagnoptics News

What is new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

Diagnoptics appoints DiosPharma as the new Korean distributor

Groningen, the Netherlands – November 7, 2016

Diagnoptics is glad to announce, that DiosPharma has been appointed as the new distributor of the AGE Reader mu in Korea. DiosPharma will be responsible for the marketing & sales as well as the regulatory approval of the AGE Reader mu in Korea. “After recently starting successful partnerships in Japan and China, this distribution agreement means another step into a major market in Asia for Diagnoptics” said Diagnoptics’ CEO Bart van den Berg.

DiosPharma will start with obtaining regulatory approval from the Korean MFDS (Ministry of Food and Drug Safety) for the AGE Reader mu. This process is expected to take 10-12 months after which DiosPharma will offer the AGE Reader mu to the Korean market.

DiosPharma Co., Ltd. is dedicated to medical device and pharmaceuticals industry since its foundation in 2008. Tim Souk, CEO of DiosPharma: “We have overcome many challenges while continuing to grow and contribute to the advancement of Korean market. We have been dedicating innovative product to medical device as non-invasive products as well as in & out licensing of generic pharmaceuticals. In order for human health to become a leader, DiosPharma will strive to lead continuous improvement through ongoing research and development and innovative solutions for healthcare.”

Distributor details DiosPharma

Share this link on:

Latest news items

  1. Breakthrough publication: diabetes screening with AGE Reader 24 November 2017
  2. AGE Reader product updates at EASD 2017 – Lisbon 13 September 2017
  3. MSP bodmann GmbH appointed as new distributor in Germany 29 June 2017
  4. New key publication: large scale study in metabolic syndrome 13 June 2017
  5. Diagnoptics appoints DiosPharma as the new Korean distributor 7 November 2016
  6. Visit Diagnoptics at the EASD congress 2016 in Munich 26 August 2016
  7. Selista appointed as new Japanese distributor for the AGE Reader mu 19 May 2016
  8. Diagnoptics bei dem DDG Kongress in Berlin 16 April 2016
  9. Diagnoptics receives Chinese market approval for AGE Reader SU 12 February 2016
  10. New patent granted to Diagnoptics in Japan and EU. 7 January 2016
More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.a